Artemisia

  • SCIENTIFIC NAMES: Artemisia annua; Benflumetol; Co-artemether; Coartem; Riamet (Novartis)
  • INDICATIONS: Fever, multidrug-resistant malaria, parasitemia, leukemia, colon cancer, diarrhea, schistosomiasis, worms, insect bites (topical)
  • SYNONYM: Asteraceae
  • CLASS: Antimalarial
  • HALF-LIFE: 10 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

None known

PREGNANCY CATEGORY: N/A

This drug profile only refers to Artemisia annua, NOT Artemisia absinthium. The latter, the main constituent of absinthe, has serious side effects, including seizures, hallucinations, and death.

Derivatives of Artemisia annua are often used in combination with piperaquine, or mefloquine in treatment of malaria. Benflumetol, Coartem and Co-artemether are a combination of artemether-lumefantrine (see separate profile).

Our database has 13 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
OTIC
LOCAL
OTHER


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric